Economic costs of anxiety disorders

Anxiety
R L DuPontH J Harwood

Abstract

Anxiety disorders are estimated to affect 26.9 million individuals in the United States at some point during their lives. This study used the human capital approach to estimate the direct and indirect costs of these highly prevalent disorders. In 1990, costs associated with anxiety disorders were $46.6 billion, 31.5% of total expenditures for mental illness. Less than one-quarter of costs associated with anxiety disorders were for direct medical treatment; over three-quarters were attributable to lost or reduced productivity. Most of these indirect costs were associated with morbidity, as mortality accounted for just 2.7% of the total. Greater availability of effective, relatively low-cost outpatient treatment could substantially reduce the economic and social burden of these common and often crippling disorders.

Citations

Dec 24, 2002·Depression and Anxiety·Hans-Ulrich Wittchen
Aug 3, 2005·Depression and Anxiety·Martin D MarciniakLouise R Levine
Mar 11, 2010·Social Psychiatry and Psychiatric Epidemiology·Pasquale RobergeMirrian Smolders
Apr 7, 2011·Social Psychiatry and Psychiatric Epidemiology·Trine Flensborg-MadsenErik Lykke Mortensen
Oct 12, 2012·Community Mental Health Journal·Emily M Johnson, Meredith E Coles
Jan 25, 2008·Journal of Abnormal Child Psychology·Denise H M BoddenSusan M Bögels
Nov 19, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Stefan G HofmannJamie Sturm
Jul 21, 2004·Current Psychiatry Reports·John M Kuzma, Donald W Black
Jun 1, 2006·Current Psychiatry Reports·Rajnish MagoElisabeth J S Kunhel
Sep 21, 2007·Current Psychiatry Reports·Pim Cuijpers, Josien Schuurmans
Jun 14, 2002·Journal of Affective Disorders·Anita PatelDavid Baldwin
Aug 28, 2003·Journal of Anxiety Disorders·Michael Van AmeringenPeter Farvolden
Nov 29, 2012·Nature Neuroscience·Mazen A KheirbekRené Hen
Apr 4, 2002·Journal of General Internal Medicine·Jeffrey S HarmanM Katherine Shear
Feb 26, 2010·Cognitive Behaviour Therapy·Pim CuijpersGerhard Andersson
Nov 7, 2007·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Yvonne W Y Chow, Hector W H Tsang
Oct 12, 2012·AIDS Patient Care and STDs·Susan S ReifKathryn Whetten
May 10, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P Andlin-Sobocki, H-U Wittchen
May 10, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Patrik Andlin-SobockiJes Olesen
Dec 20, 2013·BMC Psychiatry·Mitsuhiro SadoKimio Yoshimura
May 12, 2009·BMC Psychiatry·Tracey L SheaJulie F Pallant
Feb 1, 2007·Neuropsychiatric Disease and Treatment·Martin A Katzman, Leslie Jacobs
Sep 30, 2000·PharmacoEconomics·J D Lipsitz, F R Schneier
Jun 11, 2008·Psychosomatic Medicine·Kathryn WhettenLaura Kathleen Murphy-McMillan
Mar 15, 2006·Expert Review of Neurotherapeutics·Michael E Thase
Jun 24, 2004·Expert Opinion on Investigational Drugs·Eric P Zorrilla, George F Koob
Jan 9, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Borwin BandelowUNKNOWN World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive
Oct 25, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Borwin BandelowJohann Vega
Dec 4, 2015·Animals : an Open Access Journal From MDPI·Yi ChenPhilip Griebel
Jan 10, 2013·Journal of Anxiety Disorders·Meghan E LoveringKristin J Heaton
Dec 15, 2010·Neuroscience and Biobehavioral Reviews·Dan J Stein, Randolph M Nesse
Nov 26, 2010·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Joanna BrooksZiv Amir
Sep 8, 2010·Clinical Psychology Review·Patrick SylversJamie L LaPrairie
May 27, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Sayamwong E HammackDonald G Rainnie
Mar 10, 2009·Journal of Psychiatric Research·Holly J RamsawhJitender Sareen
Mar 10, 2016·Clinical Psychology Review·Patrick E McKnightJenna M Calton
Sep 5, 2008·Journal of Affective Disorders·Alexander KonnopkaHans-Helmut König
Oct 27, 2015·Journal of Behavior Therapy and Experimental Psychiatry·Halina J DourMichelle G Craske
Jun 27, 2007·General Hospital Psychiatry·Mark Olfson, Marc J Gameroff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Clinical Psychiatry
P E GreenbergA J Fyer
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Mickael Löthgren
Journal of Psychosomatic Research
E SouêtreG Darcourt
© 2021 Meta ULC. All rights reserved